Overview
Tryp Therapeutics is developing psilocybin-based therapies for eating disorders, fibromyalgia-associated depression, and other conditions with high unmet need. They focus on specific patient populations where psychedelic-assisted therapy may offer significant benefit.
More in Mental Health Tech
Latest industry news
Precision Neuroscience Raises $250M to Accelerate Brain-Computer Interface Development
2026-11-01 · Funding
Merge Labs Gets Competition as New Rival Neurotech Startup Enters the Consumer BCI Arena
2026-10-31 · Industry
Neuralink Connects to Grok AI Agent, Enabling ALS Patient to Control AI and Make Calls by Thought Alone
2026-10-30 · Product
Implanted BCIs Still Lack a Shared Safety Rulebook, and the Field Is Running Out of Time to Write One
2026-10-29 · Research
Company details
Category
💙 Mental Health Tech
Location
San Diego, USA
Funding
Public · CSE: TRYP
Website
tryptherapeutics.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →